Outpatient Pharmacotherapy for Neonatal Abstinence Syndrome. | Neonatal Abstinence Syndrome and Opioid Policy

Maalouf FI, Cooper WO, Slaughter JC, Dudley J, Patrick SW. Outpatient Pharmacotherapy for Neonatal Abstinence Syndrome. The Journal of pediatrics. 2018 May 7. PMID: 29754866 [PubMed]

Abstract

To determine differences in lengths of stay, length of therapy, emergency department (ED) utilization, and hospital readmissions between infants with neonatal abstinence syndrome (NAS) treated exclusively with inpatient pharmacotherapy compared with those discharged on outpatient pharmacotherapy.